Doximity, Inc. (NASDAQ:DOCS) Director Sells $67,425.00 in Stock

Doximity, Inc. (NASDAQ:DOCS) Director Kira Scherer Wampler sold 2,500 shares of the company’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $26.97, for a total value of $67,425.00. Following the completion of the transaction, the director now directly owns 10,258 shares of the company’s stock, valued at $276,658.26. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Doximity Trading Down 0.4 %

Doximity stock opened at $25.60 on Friday. Doximity, Inc. has a 12 month low of $19.71 and a 12 month high of $37.10. The business’s 50 day simple moving average is $28.03 and its 200 day simple moving average is $25.71. The company has a market cap of $4.78 billion, a price-to-earnings ratio of 38.79, a PEG ratio of 3.25 and a beta of 1.17.

Doximity (NASDAQ:DOCS) last posted its earnings results on Thursday, February 8th. The company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.06. The firm had revenue of $135.28 million for the quarter, compared to the consensus estimate of $127.46 million. Doximity had a return on equity of 16.08% and a net margin of 29.39%. As a group, equities research analysts forecast that Doximity, Inc. will post 0.72 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Doximity

Institutional investors have recently made changes to their positions in the stock. First Horizon Advisors Inc. lifted its position in shares of Doximity by 111.3% during the fourth quarter. First Horizon Advisors Inc. now owns 995 shares of the company’s stock worth $28,000 after acquiring an additional 524 shares in the last quarter. Quarry LP purchased a new stake in shares of Doximity during the first quarter worth $38,000. GAMMA Investing LLC purchased a new stake in shares of Doximity during the fourth quarter worth $40,000. American International Group Inc. purchased a new stake in shares of Doximity during the second quarter worth $43,000. Finally, Geneos Wealth Management Inc. purchased a new stake in shares of Doximity in the first quarter worth $51,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on DOCS shares. Truist Financial upped their target price on Doximity from $28.00 to $29.00 and gave the company a “hold” rating in a report on Friday, February 9th. Bank of America upped their target price on Doximity from $29.00 to $32.00 and gave the company a “neutral” rating in a report on Tuesday, January 23rd. Evercore ISI reaffirmed an “in-line” rating and issued a $30.00 target price on shares of Doximity in a report on Tuesday. Wells Fargo & Company upped their target price on Doximity from $25.00 to $27.00 and gave the company an “equal weight” rating in a report on Friday, February 9th. Finally, Leerink Partnrs reiterated a “market perform” rating on shares of Doximity in a research note on Monday, February 26th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $28.82.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.